Table 2.
Principal components (PC) | Metabolites or related DEGs1 | Transcriptomic data | Metabolomic data | ||
---|---|---|---|---|---|
N | % | N | % | ||
PC1 (Stress treatments) | R2 (%) | 39.4 | 20.9 | ||
AA+ | 140 | 37.5 | 1 | 6.7 | |
AA- | 181 | 48.5 | 8 | 53.3 | |
(AA+OA+sugar)+ | 94 | 32.2 | |||
(AA+OA+sugar- | 143 | 49.0 | |||
OA+ | 39 | 33.3 | 25 | 80.6 | |
OA- | 53 | 45.3 | 0 | 0 | |
(OA+sugar)+ | 7 | 13.7 | |||
(OA+sugar)- | 28 | 54.9 | |||
Sugar+ | 30 | 35.3 | 29 | 76.3 | |
Sugar- | 33 | 38.8 | 0 | 0 | |
PC3/PC2 (Genotypic differences) | R2 (%) | 13.5 | 13.8 | ||
AA+ | 118 | 31.6 | 8 | 53.3 | |
AA- | 60 | 19.2 | 2 | 13.3 | |
(AA+OA+sugar)+ | 72 | 24.7 | |||
(AA+OA+sugar- | 66 | 22.6 | |||
OA+ | 36 | 30.8 | 7 | 22.6 | |
OA- | 29 | 24.8 | 17 | 54.8 | |
(OA+sugar)+ | 24 | 47.1 | |||
(OA+sugar)- | 7 | 13.7 | |||
Sugar+ | 29 | 34.1 | 16 | 42.1 | |
Sugar- | 15 | 17.6 | 12 | 31.6 | |
PC2/PC3 (Genotypic difference in recovery/treatment timing) | R2 (%) | 20.3 | 13.5 | ||
AA+ | 108 | 29.0 | 13 | 86.7 | |
AA- | 102 | 27.3 | 0 | 0 | |
(AA+OA+sugar)+ | 81 | 27.7 | |||
(AA+OA+sugar- | 97 | 33.2 | |||
OA+ | 43 | 36.8 | 11 | 35.5 | |
OA- | 35 | 29.9 | 5 | 16.1 | |
(OA+sugar)+ | 24 | 47.1 | |||
(OA+sugar)- | 16 | 31.4 | |||
Sugar+ | 29 | 34.1 | 18 | 47.4 | |
Sugar- | 33 | 38.8 | 9 | 23.7 |
1 N is the number of related DEGs or metabolites showing significant positive (+) or negative (-) loading (contributions) to the corresponding principal components (PCs).